GEN DE WITTELAAN L11 A3, 2800 MECHELEN, C9
Material disclosure
Reports First Quarter 2026 Financial Results and Provides Business Update
.2 Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases Conference Call March 31, 2026
Annual and Extraordinary Shareholders’ Meetings to be Held
Issues Press Release Dated March 23, 2026
Receives Transparency Notification
Receives Transparency Notifications
Creates New Subscription Right Plan
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
No filings found
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Automatic Shelf Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Submission Upload
Correspondence